<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about ARAY</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sun, 19 May 2013 07:50:00 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=ARAY" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/accuray-lags-3q-earnings-est-analyst-blog-cm244762">
      <guid isPermaLink="false">244762</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m6S7Kw5s83I/accuray-lags-3q-earnings-est-analyst-blog-cm244762</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Accuray Lags 3Q Earnings Est - Analyst Blog</title>
      <description>Accuray Lags 3Q Earnings Est   Accuray Incorporated's  (  ARAY  ) third-quarter fiscal 2013 adjusted loss of 37 cents per share was wider than the Zacks Consensus Estimate of a loss of 21&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/m6S7Kw5s83I" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 May 2013 02:04:01 Z</pubDate>
      <a10:updated>2013-05-08T23:27:58Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MAKO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/accuray-lags-3q-earnings-est-analyst-blog-cm244762</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mygn-earnings-easily-beat-guidance-up-analyst-blog-cm244734">
      <guid isPermaLink="false">244734</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E5liiQ6dTro/mygn-earnings-easily-beat-guidance-up-analyst-blog-cm244734</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>MYGN Earnings Easily Beat, Guidance Up - Analyst Blog</title>
      <description>Myriad Genetics Inc.  (  MYGN  ) reported  earnings per share (EPS) of 46 cents in the third quarter of fiscal  2013, representing a beat of 17.9% over the Zacks Consensus  Estimate and EPS&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/E5liiQ6dTro" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 09 May 2013 01:25:01 Z</pubDate>
      <a10:updated>2013-05-08T21:30:16Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MYGN</nasdaq:tickers>
      <nasdaq:tickers>SNY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mygn-earnings-easily-beat-guidance-up-analyst-blog-cm244734</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/reiterate-becton-dickinson-at-neutral-analyst-blog-cm244332">
      <guid isPermaLink="false">244332</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-3LfeJ0-CA4/reiterate-becton-dickinson-at-neutral-analyst-blog-cm244332</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Reiterate Becton Dickinson at Neutral - Analyst Blog</title>
      <description>On May 6, we retained  Becton, Dickinson and Company  (  BDX  ) at Neutral based on the performance of the company in fiscal second quarter 2013.   Why the Retention?   On May 2, Becton&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/-3LfeJ0-CA4" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 22:22:57 Z</pubDate>
      <a10:updated>2013-05-07T19:26:29Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>BDX</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/reiterate-becton-dickinson-at-neutral-analyst-blog-cm244332</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mindray-beats-earnings-est-misses-rev-analyst-blog-cm244205">
      <guid isPermaLink="false">244205</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JckKtUlbiVA/mindray-beats-earnings-est-misses-rev-analyst-blog-cm244205</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Mindray Beats Earnings Est, Misses Rev - Analyst Blog</title>
      <description>Chinese medical devices major,  Mindray Medical  International Limited  (  MR  ) reported  first-quarter 2013 adjusted (excluding one-time expenses other than  stock-based compensation expense)&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JckKtUlbiVA" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 17:31:56 Z</pubDate>
      <a10:updated>2013-05-07T13:32:11Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mindray-beats-earnings-est-misses-rev-analyst-blog-cm244205</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/holx-beats-earnings-view-slashed-analyst-blog-cm244078">
      <guid isPermaLink="false">244078</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R3qVl3vRE6A/holx-beats-earnings-view-slashed-analyst-blog-cm244078</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>HOLX Beats Earnings, View Slashed - Analyst Blog</title>
      <description>Hologic Inc.  (  HOLX  ) reported  adjusted earnings per share of 35 cents in the second quarter of  fiscal 2013, higher than the year-ago earnings of 33 cents as well  as the company's&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/R3qVl3vRE6A" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 16:24:13 Z</pubDate>
      <a10:updated>2013-05-07T12:24:31Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HOLX</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/holx-beats-earnings-view-slashed-analyst-blog-cm244078</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/volcano-beats-earnings-downturn-ahead-analyst-blog-cm244072">
      <guid isPermaLink="false">244072</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BmjHug8F7Bc/volcano-beats-earnings-downturn-ahead-analyst-blog-cm244072</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Volcano Beats Earnings, Downturn Ahead - Analyst Blog</title>
      <description>Volcano Corporation  (  VOLC  ) reported adjusted earnings per share (EPS) of 2 cents in the first quarter of 2013. The result betters the year-ago break-even level as well as the Zacks&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/BmjHug8F7Bc" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 16:23:01 Z</pubDate>
      <a10:updated>2013-05-07T13:36:19Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>PCI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/volcano-beats-earnings-downturn-ahead-analyst-blog-cm244072</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/hma-matches-earnings-misses-rev-est-analyst-blog-cm243930">
      <guid isPermaLink="false">243930</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HF15bhaIIGk/hma-matches-earnings-misses-rev-est-analyst-blog-cm243930</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>HMA Matches Earnings, Misses Rev Est. - Analyst Blog</title>
      <description>Health Management Associates  (  HMA  ), a leading  operator of general acute care hospitals, reported first quarter  2013 adjusted (excluding one-time expenses other than stock-based&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/HF15bhaIIGk" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 06 May 2013 22:20:01 Z</pubDate>
      <a10:updated>2013-05-06T18:25:03Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ACHC</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>HMA</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/hma-matches-earnings-misses-rev-est-analyst-blog-cm243930</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/thoratec-misses-earnings-and-rev-est-analyst-blog-cm243797">
      <guid isPermaLink="false">243797</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CsNGRI8B5AE/thoratec-misses-earnings-and-rev-est-analyst-blog-cm243797</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Thoratec Misses Earnings and Rev Est - Analyst Blog</title>
      <description>Thoratec Corp.  (  THOR  ) reported first-quarter 2013 adjusted (excluding one-time items other than stock-based compensation expenses) earnings per share of 34 cents missing the Zacks&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/CsNGRI8B5AE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 06 May 2013 17:26:08 Z</pubDate>
      <a10:updated>2013-05-06T15:29:46Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>BTT</nasdaq:tickers>
      <nasdaq:tickers>HTWR</nasdaq:tickers>
      <nasdaq:tickers>THOR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/thoratec-misses-earnings-and-rev-est-analyst-blog-cm243797</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/mwi-vet-earnings-beat-sales-miss-analyst-blog-cm243484">
      <guid isPermaLink="false">243484</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n8O-BTQz7Ms/mwi-vet-earnings-beat-sales-miss-analyst-blog-cm243484</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>MWI Vet Earnings Beat, Sales Miss - Analyst Blog</title>
      <description>MWI Veterinary Supply  (  MWIV  ) reported second-quarter fiscal 2013 earnings per share (EPS) of $1.19, up 4.4% on a year-over-year basis. The result also surpassed the Zacks Consensus&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/n8O-BTQz7Ms" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 20:44:45 Z</pubDate>
      <a10:updated>2013-05-03T17:34:56Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>COO</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>MWIV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/mwi-vet-earnings-beat-sales-miss-analyst-blog-cm243484</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/abiomed-earnings-beat-in-4q-analyst-blog-cm243445">
      <guid isPermaLink="false">243445</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NDdPQkNSJ2A/abiomed-earnings-beat-in-4q-analyst-blog-cm243445</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Abiomed Earnings Beat in 4Q - Analyst Blog</title>
      <description>Abiomed Inc.  's (  ABMD  ) fourth-quarter fiscal 2013 earnings per share (EPS) of 9 cents beat the Zacks Consensus Estimate of 7 cents by 28.6%. The Massachusetts.-based company registered a&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/NDdPQkNSJ2A" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 18:31:52 Z</pubDate>
      <a10:updated>2013-05-03T15:33:16Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>IDE</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/abiomed-earnings-beat-in-4q-analyst-blog-cm243445</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/masimo-matches-earnings-est-analyst-blog-cm243422">
      <guid isPermaLink="false">243422</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OWPHr-viXTE/masimo-matches-earnings-est-analyst-blog-cm243422</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Masimo Matches Earnings Est. - Analyst Blog</title>
      <description>Masimo Corporation  (  MASI  ), a leader in non-invasive monitoring technology for patient care, recorded first quarter 2013 earnings per share of 28 cents thereby matching the Zacks Consensus&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/OWPHr-viXTE" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 03 May 2013 17:32:33 Z</pubDate>
      <a10:updated>2013-05-03T14:34:27Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>EEA</nasdaq:tickers>
      <nasdaq:tickers>MAS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/masimo-matches-earnings-est-analyst-blog-cm243422</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/merge-1q13-loss-widens-meets-est-analyst-blog-cm243238">
      <guid isPermaLink="false">243238</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/obo1CDOeo10/merge-1q13-loss-widens-meets-est-analyst-blog-cm243238</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Merge 1Q13: Loss Widens; Meets Est  - Analyst Blog</title>
      <description>Merge Healthcare Incorporated  (  MRGE  ) reported net loss of 7 cents per share in the first quarter of 2013, worse than the year-ago net loss of 2 cents per share. Considering stock-based&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/obo1CDOeo10" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 May 2013 23:26:05 Z</pubDate>
      <a10:updated>2013-05-02T20:33:07Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>ISRG</nasdaq:tickers>
      <nasdaq:tickers>MRGE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/merge-1q13-loss-widens-meets-est-analyst-blog-cm243238</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/dexcom-loss-narrower-than-est-analyst-blog-cm243215">
      <guid isPermaLink="false">243215</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I3N2rp_0Vic/dexcom-loss-narrower-than-est-analyst-blog-cm243215</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>DexCom Loss Narrower than Est. - Analyst Blog</title>
      <description>DexCom, Inc.  (  DXCM  ), a player in the glucose monitoring market, reported first quarter 2013 adjusted loss per share of 16 cents, narrower than the Zacks Consensus Estimate of a loss of 17&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/I3N2rp_0Vic" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 02 May 2013 22:26:20 Z</pubDate>
      <a10:updated>2013-05-02T19:28:16Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>CPHD</nasdaq:tickers>
      <nasdaq:tickers>DXCM</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/dexcom-loss-narrower-than-est-analyst-blog-cm243215</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/sluggish-segments-sour-cvs-earnings-beat-analyst-blog-cm242623">
      <guid isPermaLink="false">242623</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LeQxaoUPGgc/sluggish-segments-sour-cvs-earnings-beat-analyst-blog-cm242623</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Sluggish Segments Sour CVS Earnings Beat - Analyst Blog</title>
      <description>CVS Caremark  (  CVS  ) reported first-quarter 2013 earnings per share (EPS) of 77 cents, up 29.9% year over year. However, excluding one-time expenses, the adjusted EPS rose 28.1% to 83&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LeQxaoUPGgc" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 01 May 2013 18:51:10 Z</pubDate>
      <a10:updated>2013-05-01T15:52:05Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>BIOS</nasdaq:tickers>
      <nasdaq:tickers>CVS</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>RAD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/sluggish-segments-sour-cvs-earnings-beat-analyst-blog-cm242623</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/luminex-beats-1q-earnings-est-analyst-blog-cm242399">
      <guid isPermaLink="false">242399</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Ex-4sSghAk/luminex-beats-1q-earnings-est-analyst-blog-cm242399</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Luminex Beats 1Q Earnings Est. - Analyst Blog</title>
      <description>Luminex Corporation  's (  LMNX  ) first-quarter 2013 adjusted earnings per share of 14 cents beat the Zacks Consensus Estimate of 8 cents per share by 75%. It also exceeded the year-ago&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/8Ex-4sSghAk" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 01 May 2013 13:47:17 Z</pubDate>
      <a10:updated>2013-05-01T10:49:23Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABMD</nasdaq:tickers>
      <nasdaq:tickers>ARAY</nasdaq:tickers>
      <nasdaq:tickers>LMNX</nasdaq:tickers>
      <nasdaq:tickers>MRK</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/luminex-beats-1q-earnings-est-analyst-blog-cm242399</feedburner:origLink></item>
  </channel>
</rss>
